Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure

Anthony J Choi; Sunu S Thomas; Jagmeet P Singh

doi:10.1016/j.hfc.2016.03.010

Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure

Heart Fail Clin. 2016 Jul;12(3):423-36. doi: 10.1016/j.hfc.2016.03.010.

Authors

Anthony J Choi¹, Sunu S Thomas², Jagmeet P Singh³

Affiliations

¹ Electrophysiology Laboratory, Cardiac Arrhythmia Service, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.
² Heart Failure & Transplant Services, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.
³ Electrophysiology Laboratory, Cardiac Arrhythmia Service, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: JSINGH@mgh.harvard.edu.

PMID: 27371518
DOI: 10.1016/j.hfc.2016.03.010

Abstract

Patients with advanced heart failure are at high risk for progression of their disease and sudden cardiac death. The role of device therapy in this patient population continues to evolve and is directed toward improving cardiac pump function and/or reducing sudden arrhythmic death.

Keywords: Arrhythmia; CIED; Cardiac resynchronization therapy; Defibrillator; Heart failure.

Publication types

Review

MeSH terms

Cardiac Resynchronization Therapy / methods*
Death, Sudden, Cardiac / prevention & control
Defibrillators, Implantable
Female
Heart Failure / physiopathology
Heart Failure / therapy*
Humans
Male
Quality of Life
Survival Analysis
Treatment Outcome
Ventricular Remodeling